Search

Ocugen Inc

Închisă

1.44 1.41

Rezumat

Modificarea prețului

24h

Curent

Minim

1.41

Maxim

1.49

Indicatori cheie

By Trading Economics

Venit

-1.5M

-19M

Vânzări

1.7M

1.5M

EPS

-0.06

Marjă de profit

-1,250.946

Angajați

116

EBITDA

-987K

-17M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+544.67% upside

Dividende

By Acuity

Următoarele câștiguri

31 iul. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-122M

504M

Deschiderea anterioară

0.03

Închiderea anterioară

1.44

Ocugen Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

8 iul. 2026, 23:56 UTC

Sirius XM Holdings Inc shares are higher in after-market hours, remaining above their 20-day moving average and near the upper end of their one-month trading range.

8 iul. 2026, 23:56 UTC

MercadoLibre Inc. shares declined during after-market hours, reflecting broader market sentiment amid rising oil prices and inflationary pressures from Middle East tensions.

8 iul. 2026, 23:56 UTC

Biogen Inc shares are lower in after-market hours, continuing a trend of four consecutive sessions finishing lower, with no specific news identified for the decline.

8 iul. 2026, 23:52 UTC

UK House Price Balance Declines to -0.33%, Heightening Concerns Over Housing Market Stability Amid Economic Pressures

8 iul. 2026, 23:52 UTC

Positive Shift in U.S. Home Sales Anticipated as June Data Shows 5.9% Year-over-Year Increase Ahead of July Release.

8 iul. 2026, 23:52 UTC

Optimism Grows Ahead of July 9 Release for U.S. Existing Home Sales Amid Lower Mortgage Rates and Increased Listings

8 iul. 2026, 23:52 UTC

Australia's Westpac Consumer Confidence Index shows a 3.5% drop, signaling ongoing economic concerns ahead of July 14 release amid inflationary pressures and market volatility.

8 iul. 2026, 23:52 UTC

Australia's Westpac Consumer Confidence Index set for July 14, 2026 release amid cautious investor sentiment and global economic pressures.

8 iul. 2026, 23:51 UTC

Gilead Sciences shares are lower in after-hours trading, reflecting a decline from earlier levels amid broader market weakness influenced by geopolitical tensions.

8 iul. 2026, 23:51 UTC

News

Broadcom shares rise in after-market hours as analysts project $172 billion in revenue next year, driven by AI infrastructure spending.

8 iul. 2026, 23:51 UTC

U.S. equity markets show mixed results amid rising oil prices and geopolitical tensions, with European markets declining sharply as inflation fears grow.

8 iul. 2026, 23:51 UTC

Geopolitical tensions and rising oil prices drive mixed Asian equity markets, with European indices declining amid inflation concerns and revised global growth forecasts.

8 iul. 2026, 23:51 UTC

Global equity markets decline amid rising oil prices and geopolitical tensions, with U.S. consumer credit unexpectedly falling.

8 iul. 2026, 23:51 UTC

European equity markets drop as DAX 30 falls 2.5% amid escalating Middle East tensions, rising oil prices, and inflation concerns.

8 iul. 2026, 23:51 UTC

Macro News
ETF Constituents
Correlated Moves

Materials Select Sector SPDR Fund declines in after-market hours amid geopolitical tensions affecting global oil markets and related asset sentiment.

8 iul. 2026, 23:51 UTC

News
Social Media

Costco Wholesale reported net sales of $29.24 billion for June but shares declined in after-hours trading amid mixed investor sentiment and broader market trends.

8 iul. 2026, 23:51 UTC

Correlated Moves

The NZD/HKD is higher today, reflecting a modest increase since Tuesday's close, despite declines in European markets, including the DAX 30 Index.

8 iul. 2026, 23:51 UTC

Correlated Moves
Macro News

The New Zealand Dollar has strengthened against major currencies after the Reserve Bank raised its key interest rate to 2.50%.

8 iul. 2026, 23:51 UTC

Macro News
ETF Constituents

iShares MSCI South Korea ETF declines in after-market hours amid KOSPI's significant drop and rising global economic concerns linked to Middle East tensions.

8 iul. 2026, 23:51 UTC

Macro News
ETF Constituents

The iShares U.S. Aerospace & Defense ETF declined in after-market trading amid rising tensions from U.S. military strikes against Iranian targets, impacting key defense firms.

8 iul. 2026, 23:51 UTC

Correlated Moves
Macro News

Bitcoin is trading lower amid rising geopolitical tensions following President Trump's ceasefire announcement with Iran. Earlier, it reached a session high before declining.

8 iul. 2026, 23:46 UTC

Biomarin Pharmaceutical Inc shares are higher in after-market hours, reflecting routine trading activity with minimal fluctuations and positioning above the 20-day moving average.

8 iul. 2026, 23:46 UTC

Fastenal Co shares are trading lower in after-market hours, marking the fifth consecutive day of declines amid broader market weakness linked to geopolitical tensions.

8 iul. 2026, 23:46 UTC

Vertex Pharmaceuticals shares are higher in after-market trading, despite significant declines in European markets amid geopolitical tensions involving the U.S. and Iran.

8 iul. 2026, 23:46 UTC

News
ETF Constituents
Macro News
Correlated Moves

The Financial Select Sector SPDR Fund is higher in after-market trading, supported by strong seasonal patterns and movements in major bank holdings.

8 iul. 2026, 23:46 UTC

Western Digital shares are lower in after-market trading, amid broader market declines linked to geopolitical tensions affecting oil supply routes.

8 iul. 2026, 23:41 UTC

News
Social Media
Correlated Moves

Advanced Micro Devices shares are declining in after-hours trading amid negative sentiment in semiconductor stocks, following the announcement of its upcoming earnings report.

8 iul. 2026, 23:41 UTC

U.S. 30-Year Mortgage Rate Rises to 6.58%, Sparking Decline in Applications Amid Inflation and Economic Uncertainty

8 iul. 2026, 23:41 UTC

Social Media
News

NVIDIA Corp shares declined in after-market trading amid concerns over AI spending and competition. Analysts note cautious investor sentiment contributing to the bearish outlook.

8 iul. 2026, 23:41 UTC

News
Social Media
Correlated Moves

Micron Technology shares traded higher after notable options activity, with $7.2 million in orders for $815 7/17 Puts contributing to a total premium of over $21.5 million.

Comparație

Modificare preț

Ocugen Inc Așteptări

Obiectiv de preț

By TipRanks

544.67% sus

Prognoză pe 12 luni

Medie 9.67 USD  544.67%

Maxim 12 USD

Minim 7 USD

În baza a 6 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruOcugen Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

6 ratings

6

Cumpărare

0

Păstrare

0

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.
help-icon Live chat